AMENDMENT TO FACILITY AGREEMENTSAgreements • February 6th, 2013 • Array Biopharma Inc • Pharmaceutical preparations
This Amendment to Facility Agreements (this “Amendment”) is hereby entered into as of December 28, 2012 by and between Array BioPharma Inc. (“Array”) and Deerfield Private Design Fund, L.P. and Deerfield Private Design International, L.P. (“Deerfield”).
EIGHTH AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • February 6th, 2013 • Array Biopharma Inc • Pharmaceutical preparations
This Eighth Amendment to Loan and Security Agreement (this “Amendment”) is entered into as of December 28, 2012, by and between COMERICA BANK (“Bank”) and ARRAY BIOPHARMA, INC. (“Borrower”).
THIRD AMENDMENT TO DRUG DISCOVERY AND DEVELOPMENT AGREEMENTDiscovery and Development Agreement • February 6th, 2013 • Array Biopharma Inc • Pharmaceutical preparations
THIS THIRD AMENDMENT TO DRUG DISCOVERY AND DEVELOPMENT AGREEMENT (“Amendment”), effective as of November 29, 2012 (the “Amendment Date”), is entered into by and between Celgene Corporation, a Delaware corporation, having a principal place of business 86 Morris Avenue, Summit, NJ 07901 (“Celgene”), and Array BioPharma Inc., a Delaware corporation, having a principal place of business at 3200 Walnut Street, Boulder, Colorado 80301 (“Array”). Celgene and Array are sometimes referred to herein individually as a “Party” and collectively as the “Parties.” Capitalized terms used but not defined herein have the meaning assigned to them in the Agreement (as defined below).
